The resale registration creates a significant overhang of ~30.5% of outstanding shares, with B. Riley Principal Capital alone holding 460,080 shares (10% of outstanding). Monitor for selling activity by insiders and B. Riley, which could pressure the stock. The going-concern qualification suggests the company may need additional capital, increasing the risk of further dilutive offerings.
Price Chart
Executive Summary
Biomerica filed an S-3 shelf registration to register 1,403,705 shares of common stock for resale by selling stockholders, primarily from an August 20, 2026 private placement of 1,393,705 shares. The company will not receive any proceeds from this resale registration. The filing also incorporates by reference the company's 10-K, which includes a going-concern qualification from its auditor, indicating substantial doubt about the company's ability to continue as a going concern.
Key Facts
- S-3 registers 1,403,705 shares for resale by selling stockholders; company receives no proceeds
- Shares were issued in an August 20, 2026 private placement (1,393,705 shares) and a consulting agreement (10,000 shares)
- As of September 23, 2026, there were 4,598,968 shares outstanding; the registered shares represent ~30.5% of outstanding
- B. Riley Principal Capital, LLC, a 10% holder and financial advisor, is the largest selling stockholder (460,080 shares)
- Auditor's report includes an explanatory paragraph expressing substantial doubt about the company's ability to continue as a going concern
- Last reported sale price on September 23, 2026 was $2.60 per share; maximum aggregate offering price estimated at $3,277,580.99
Financial Impact
Up to 1,403,705 shares (30.5% of outstanding) registered for resale; at $2.60/share, potential market overhang of ~$3.65M
Risk Factors
- Potential near-term selling pressure from up to 1.4M shares registered for resale
- Going-concern qualification indicates financial distress and potential need for additional dilutive capital
- B. Riley Principal Capital, a 10% holder and financial advisor, may sell its entire 460,080-share position
- Insiders (CEO, directors) are also selling stockholders, signaling potential lack of confidence
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001493152-26-044165 |
| Exhibit: ex107.htm | 0001493152-26-044165 |
| Exhibit: ex5-1.htm | 0001493152-26-044165 |
| Exhibit: ex23-1.htm | 0001493152-26-044165 |
| Document: 0001493152-26-044165-index-headers.html | 0001493152-26-044165 |
| Document: 0001493152-26-044165-index.html | 0001493152-26-044165 |
| Document: 0001493152-26-044165.txt | 0001493152-26-044165 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | DEF 14A | $1.76 | awaiting T+20 | — | $1.72 (−2.27%) |
Oct 15, 2026 11d ago | 8-K | $1.85 | awaiting T+20 | — | $1.72 (−7.03%) |
Oct 8, 2026 18d ago | EFFECT | $1.89 | awaiting T+20 | — | $1.72 (−8.99%) |
Oct 8, 2026 18d ago | EFFECT | $1.89 | awaiting T+20 | — | $1.72 (−8.99%) |
Sep 25, 2026 4w ago | S-3 | $2.32 $1.68 | ▲ +27.59% | ▲ +26.11% | $1.72 (+25.86%) |
Sep 24, 2026 4w ago | S-3 | $2.32 $1.68 | ▲ +27.59% | ▲ +26.11% | $1.72 (+25.86%) |
Sep 1, 2026 7w ago | Press Release | $2.09 $2.26 | ▲ +8.13% | ▲ +7.82% | $1.72 (−17.70%) |
Aug 27, 2026 8w ago | Insider Cluster | $2.14 $2.39 | ▲ +11.68% | ▲ +12.16% | $1.72 (−19.63%) |
Aug 26, 2026 8w ago | 8-K | $2.10 $2.40 | ▼ −14.29% | ▼ −14.39% | $1.72 (+18.10%) |
Jun 4, 2026 20w ago | 8-K | $2.12 $1.73 | ▼ −18.40% | ▼ −20.26% | $1.72 (−18.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers